[New post] Sage Therapeutics (SAGE)

alanyeo posted: " Consensus revenue estimates fall to US$7.57m The consensus outlook for revenues in 2021 has deteriorated. 2021 revenue forecast decreased from US$9.14m to US$7.57m.Forecast losses increased from -US$7.00 to -US$7.33 per share.Biotechs industry in t" Respond to this post by replying above this line New post on Alpha Edge Investing Sage Therapeutics (SAGE) by alanyeo Consensus revenue estimates fall to US$7.57m The consensus outlook for revenues in 2021 has deteriorated. 2021 revenue forecast decreased from US$9.14m to US$7.57m. Forecast losses increased from -US$7.00 to -US$7.33 per share. Biotechs industry in the US expected to see average net income decline 21% next year. Consensus price target down from US$87.53 to US$83.00. […] Read more of this post alanyeo | August 10, 2021 at 3:01 pm | Categories: Equities - Research Reports by Brokers/ Banks | URL: https://wp.me/p7fA1-2KS Comment    See all comments    Like Unsubscribe to no longer receive posts from Alpha Edge Investing. Change your email settings at Manage Subscriptions. Trouble clicking? Copy and paste this URL into your browser: http://alphaedgeinvesting.com/2021/08/10/sage-therapeutics-sage-2/ Thanks for flying with WordPress.com